Cell Signals Influencing Hepatic Fibrosis

Liver fibrosis is the result of the entire organism responding to a chronic injury. Every cell type in the liver contributes to the fibrosis. This paper first discusses key intracellular signaling pathways that are induced during liver fibrosis. The paper then examines the effects of these signaling pathways on the major cell types in the liver. This will provide insights into the molecular pathophysiology of liver fibrosis and should identify therapeutic targets.

• Publication year

  2012

• Venue

  International Journal of Hepatology

• Publication date

  2012-08-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1155/2012/158547PMID 22973518PMCID 3437636
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endothelial dysfunction in the regulation of cirrhosis and portal hypertension

  2012cited by this paper
• Liver regeneration.

  2012cited by this paper
• Protection from liver fibrosis by a peroxisome proliferator-activated receptor δ agonist

  2012cited by this paper
• Bacterial translocation and changes in the intestinal microbiome associated with alcoholic liver disease.

  2012cited by this paper
• Differential Regulation of TGF-β/Smad Signaling in Hepatic Stellate Cells between Acute and Chronic Liver Injuries

  2012cited by this paper
• Transforming growth factor-β and smooth muscle differentiation.

  2012cited by this paper
• Role of innate immunity and the microbiota in liver fibrosis: crosstalk between the liver and gut

  2012cited by this paper
• Bacterial translocation and changes in the intestinal microbiome in mouse models of liver disease.

  2012cited by this paper
• Signal Transducer and Activator of Transcription 3 in Liver Diseases: A Novel Therapeutic Target

  2011influential reference
• Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis‐associated carcinogenesis

  2011cited by this paper
• Is it the end of the line for the EMT?

  2011cited by this paper
• Hepatic Deletion of Smad7 in Mouse Leads to Spontaneous Liver Dysfunction and Aggravates Alcoholic Liver Injury

  2011cited by this paper
• Liver fibrogenic cells.

  2011cited by this paper
• Molecular mechanisms of liver regeneration and protection for treatment of liver dysfunction and diseases

  2011cited by this paper
• Lineage tracing demonstrates no evidence of cholangiocyte epithelial‐to‐mesenchymal transition in murine models of hepatic fibrosis

  2011cited by this paper
• Innate immunity in alcoholic liver disease.

  2011cited by this paper
• In vivo treatment of HCV core-positive HepG2 cells with the transfer of recombinant caspase-3 using a 2'-5' OAS promoter.

  2011cited by this paper
• Smad phosphoisoform signals in acute and chronic liver injury: similarities and differences between epithelial and mesenchymal cells

  2011influential reference
• Toll-like receptors in acute liver injury and regeneration.

  2011cited by this paper
• Leptin and acetaldehyde synergistically promotes αSMA expression in hepatic stellate cells by an interleukin 6-dependent mechanism.

  2011cited by this paper
• Fibronectin splice variants: Understanding their multiple roles in health and disease using engineered mouse models

  2011cited by this paper
• The Role of Cilia in the Regulation of Bile Flow

  2011cited by this paper
• Molecular mechanisms of alcoholic liver disease: innate immunity and cytokines.

  2011cited by this paper
• Controlling angiogenesis by two unique TGF-β type I receptor signaling pathways.

  2011cited by this paper
• Cholangiocyte N-Ras Protein Mediates Lipopolysaccharide-induced Interleukin 6 Secretion and Proliferation*

  2011cited by this paper
• A single NFκB system for both canonical and non-canonical signaling

  2011influential reference
• NOX1/nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation

  2011cited by this paper
• Fibrosis in Autoimmune and Cholestatic Liver Disease

  2011cited by this paper
• Recent advances in liver stem cell therapy

  2010cited by this paper
• Genetic labeling does not detect epithelial-to-mesenchymal transition of cholangiocytes in liver fibrosis in mice.

  2010cited by this paper
• Distinct proteomic features of two fibrogenic liver cell populations: Hepatic stellate cells and portal myofibroblasts

  2010cited by this paper
• Endothelial cell toll‐like receptor 4 regulates fibrosis‐associated angiogenesis in the liver

  2010cited by this paper
• Immune tolerance: what is unique about the liver.

  2010influential reference
• Hepatocytes do not undergo epithelial‐mesenchymal transition in liver fibrosis in mice

  2010cited by this paper
• Fibroblast-specific protein 1 identifies an inflammatory subpopulation of macrophages in the liver

  2010cited by this paper
• Integrins modulate cellular fibrogenesis at multiple levels; Regulation of TGF-β signaling.

  2010cited by this paper
• Cultivating hepatocytes on printed arrays of HGF and BMP7 to characterize protective effects of these growth factors during in vitro alcohol injury.

  2010cited by this paper
• Portal fibroblasts: Underappreciated mediators of biliary fibrosis

  2010cited by this paper
• Leptin Promotes the Myofibroblastic Phenotype in Hepatic Stellate Cells by Activating the Hedgehog Pathway

  2010cited by this paper
• Intrahepatic angiogenesis and sinusoidal remodeling in chronic liver disease: new targets for the treatment of portal hypertension?

  2010cited by this paper
• CX3CL1‐CX3CR1 interaction prevents carbon tetrachloride‐induced liver inflammation and fibrosis in mice

  2010cited by this paper
• Toll-Like Receptor Signaling and Liver Fibrosis

  2010influential reference
• Update on the pathophysiology of liver fibrosis

  2010cited by this paper
• Signal transducer and activator of transcription 3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis.

  2010cited by this paper
• Interleukin‐22 treatment ameliorates alcoholic liver injury in a murine model of chronic‐binge ethanol feeding: Role of signal transducer and activator of transcription 3

  2010cited by this paper
• Lack of glycoprotein 130/signal transducer and activator of transcription 3-mediated signaling in hepatocytes enhances chronic liver injury and fibrosis progression in a model of sclerosing cholangitis.

  2010influential reference
• Anti-inflammatory and anti-apoptotic roles of endothelial cell STAT3 in alcoholic liver injury.

  2010cited by this paper
• Targeted disruption of Smad3 confers resistance to the development of dimethylnitrosamine‐induced hepatic fibrosis in mice

  2009cited by this paper
• TGF-β signaling in vascular biology and dysfunction

  2009cited by this paper
• The liver as a lymphoid organ.

  2009cited by this paper
• The tumor suppressor protein PTEN inhibits rat hepatic stellate cell activation

  2009cited by this paper
• Loss of STAT5 causes liver fibrosis and cancer development through increased TGF-β and STAT3 activation

  2009cited by this paper
• Periductal interleukin‐17 production in association with biliary innate immunity contributes to the pathogenesis of cholangiopathy in primary biliary cirrhosis

  2009cited by this paper
• Biomarkers for epithelial-mesenchymal transitions.

  2009cited by this paper
• p75 neurotrophin receptor signaling regulates hepatic myofibroblast proliferation and apoptosis in recovery from rodent liver fibrosis

  2009cited by this paper
• Transcriptional regulation of hepatic stellate cells.

  2009cited by this paper
• CCR2 promotes hepatic fibrosis in mice

  2009cited by this paper
• Mesenchymal origin of hepatic stellate cells, submesothelial cells, and perivascular mesenchymal cells during mouse liver development

  2009cited by this paper
• Smad2 and Smad3 phosphorylated at both linker and COOH-terminal regions transmit malignant TGF-beta signal in later stages of human colorectal cancer.

  2009cited by this paper
• Thymus cell antigen‐1‐expressing cells in the oval cell compartment

  2009cited by this paper
• Pin1 Promotes Transforming Growth Factor-β-induced Migration and Invasion*

  2009cited by this paper
• BMP-7 as antagonist of organ fibrosis.

  2009cited by this paper
• Inhibition of c‐Jun NH2‐terminal kinase switches Smad3 signaling from oncogenesis to tumor‐ suppression in rat hepatocellular carcinoma

  2009cited by this paper
• A CK19CreERT knockin mouse line allows for conditional DNA recombination in epithelial cells in multiple endodermal organs

  2008cited by this paper
• The role of matrix stiffness in regulating cell behavior

  2008cited by this paper
• A Role for VEGF as a Negative Regulator of Pericyte Function and Vessel Maturation

  2008cited by this paper
• TLR polymorphisms and the risk of invasive fungal infections.

  2008cited by this paper
• IKK1 and IKK2 cooperate to maintain bile duct integrity in the liver

  2008cited by this paper
• Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition.

  2008cited by this paper
• Cellular and molecular mechanisms of fibrosis

  2008cited by this paper
• Fibrogenesis of parenchymal organs.

  2008cited by this paper
• Myofibroblast - like cells and liver fibrogenesis: Emerging concepts in a rapidly moving scenario.

  2008cited by this paper
• Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans.

  2008cited by this paper
• Thy-1 is expressed in myofibroblasts but not found in hepatic stellate cells following liver injury

  2008cited by this paper
• Hepatic stellate cells secrete angiopoietin 1 that induces angiogenesis in liver fibrosis.

  2008cited by this paper
• Disruption of the Smad7 gene enhances CCI4-dependent liver damage and fibrogenesis in mice

  2008cited by this paper
• Transforming growth factor beta-induced endothelial-to-mesenchymal transition: a switch to cardiac fibrosis?

  2008cited by this paper
• Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells.

  2008cited by this paper
• Toll‐like receptors and adaptor molecules in liver disease: Update

  2008cited by this paper
• A role for VEGF as a negative regulator of pericyte function and vessel maturation.

  2008cited by this paper
• VE‐cadherin is a critical endothelial regulator of TGF‐β signalling

  2008cited by this paper
• New insights into form and function of fibronectin splice variants

  2008influential reference
• Mechanisms of Fibrogenesis

  2008influential reference
• Phenotypic change in portal fibroblasts in biliary fibrosis.

  2008cited by this paper
• The transcriptional coactivator and acetyltransferase p300 in fibroblast biology and fibrosis

  2007cited by this paper
• Perspectives on endothelial-to-mesenchymal transition: potential contribution to vascular remodeling in chronic pulmonary hypertension.

  2007cited by this paper
• Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.

  2007cited by this paper
• Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases.

  2007cited by this paper
• Thy-1 is an in vivo and in vitro marker of liver myofibroblasts

  2007cited by this paper
• Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation.

  2007cited by this paper
• Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor β signaling, promoting cirrhosis and hepatocellular carcinoma

  2007cited by this paper
• TLR4 enhances TGF-beta signaling and hepatic fibrosis.

  2007cited by this paper
• Understanding the biology of angiogenesis: review of the most important molecular mechanisms.

  2007cited by this paper
• Hedgehog-mediated mesenchymal–epithelial interactions modulate hepatic response to bile duct ligation

  2007cited by this paper
• Gene expression profiles during hepatic stellate cell activation in culture and in vivo.

  2007influential reference
• Vascular endothelial dysfunction in cirrhosis.

  2007cited by this paper
• TLR4 enhances TGF-β signaling and hepatic fibrosis

  2007influential reference
• Endothelial-to-mesenchymal transition contributes to cardiac fibrosis

  2007cited by this paper
• p75 neurotrophin receptor regulates tissue fibrosis through inhibition of plasminogen activation via a PDE4/cAMP/PKA pathway

  2007cited by this paper
• Fibroblasts Derive from Hepatocytes in Liver Fibrosis via Epithelial to Mesenchymal Transition*

  2007cited by this paper

• The Rise of Fentanyl: Molecular Aspects and Forensic Investigations

  2025cites this paper
• Intestinal Bacterial Dysbiosis and Liver Fibrosis in Mice Through Gut‐Liver Axis and NLRP3 Inflammatory Pathway Caused by Fine Particulate Matter

  2025cites this paper
• Protected biofactors and antioxidants reduce the negative consequences of virus and cold challenge by modulating immunometabolism via changes in the interleukin-6 receptor signaling cascade in the liver

  2024cites this paper
• Biochanin A in murine Schistosoma mansoni infection: effects on inflammation, oxidative stress and fibrosis

  2023cites this paper
• KLF10 Inhibits TGF-β-Mediated Activation of Hepatic Stellate Cells via Suppression of ATF3 Expression

  2023cites this paper
• Melatonin and metformin co-loaded nanoliposomes efficiently attenuate liver damage induced by bile duct ligation in rats

  2023cites this paper
• Synthesis of and anti-fibrotic effect of pyrazole derivative J-1048: Inhibition of ALK5 as a novel approach to liver fibrosis targeting inflammation.

  2023cites this paper
• Effects of exosomes of mesenchymal stem cells on cholesterol-induced hepatic fibrogenesis

  2023cites this paper
• Reprogramming activated hepatic stellate cells by siRNA-loaded nanocarriers reverses liver fibrosis in mice.

  2023cites this paper
• Imatinib suppresses activation of hepatic stellate cells by targeting STAT3/IL‐6 pathway through miR‐124

  2023cites this paper
• Estrogen/estrogen receptor activation protects against DEN-induced liver fibrosis in female rats via modulating TLR-4/NF-kβ signaling.

  2023cites this paper
• MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization

  2022cites this paper
• MyD88 in hepatic stellate cells enhances liver fibrosis via promoting macrophage M1 polarization

  2022cites this paper
• All Trans-Retinoic Acids Facilitate the Remodeling of 2D and 3D Cultured Human Conjunctival Fibroblasts

  2022cites this paper
• Vildagliptin alleviates liver fibrosis in NASH diabetic rats via modulation of insulin resistance, oxidative stress, and inflammatory cascades.

  2022cites this paper
• Genome-wide CRISPR Screening to Identify Drivers of TGF-β-Induced Liver Fibrosis in Human Hepatic Stellate Cells

  2022cites this paper
• Transcriptional regulation of alcohol induced liver fibrosis in a translational porcine hepatocellular carcinoma model.

  2021cites this paper
• Antifibrotic Effects of Kangxian Ruangan Capsule on Rats with Nonalcoholic Fatty Liver Fibrosis and Hepatic Stellate Cells through Regulation of TGF-β and TLR4 Signaling Pathways

  2021cites this paper
• Ameliorative effects of Schisandrin B on Schistosoma mansoni-induced hepatic fibrosis in vivo

  2021cites this paper
• Pathophysiology and Treatment Options for Hepatic Fibrosis: Can It Be Completely Cured?

  2021cites this paper
• Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development

  2021cites this paper
• Role of necroptosis in chronic hepatic inflammation and fibrosis in a mouse model of increased oxidative stress.

  2021cites this paper
• Perturbation of Specific Signaling Pathways Is Involved in Initiation of Mouse Liver Fibrosis

  2020cites this paper
• Antifibrotic Activity of Phaleria macrocarpa Extract in Rat Liver-fibrosis Model: Focus on Oxidative Stress Markers, TGF-β1 and MMP-13

  2020cites this paper
• Role of necroptosis in chronic hepatic inflammation and liver disease in Cu/Zn superoxide dismutase deficient mice

  2020influential citation
• Neovascularization is a key feature of liver fibrosis progression: anti-angiogenesis as an innovative way of liver fibrosis treatment

  2020cites this paper
• Serum cytokines, adipokines and ferritin for non-invasive assessment of liver fibrosis in chronic liver disease: a systematic review

  2019cites this paper
• Alogliptin alleviates liver fibrosis via suppression of activated hepatic stellate cell.

  2019cites this paper
• Knockdown of CSRP3 inhibits differentiation of chicken satellite cells by promoting TGF-β/Smad3 signaling.

  2019cites this paper
• All‑trans‑retinoic acid modulates TGF‑β‑induced apoptosis, proliferation, migration and extracellular matrix synthesis of conjunctival fibroblasts by inhibiting PI3K/AKT signaling.

  2019cites this paper
• Role of Granulocyte Colony-stimulating Factor Therapy in Cirrhosis, ‘Inside Any Deep Asking Is the Answering’

  2019cites this paper
• Hepatoprotective Effect of Garcinol in Acute Paracetamol Induced and Chronic Alcohol Induced Liver Injury in Experimental Rats

  2019cites this paper
• Towards grouping concepts based on new approach methodologies in chemical hazard assessment: the read-across approach of the EU-ToxRisk project

  2019cites this paper
• Childhood obesity: an overview of laboratory medicine, exercise and microbiome

  2019cites this paper
• Effects of sub-chronic exposure to atmospheric PM2.5 on fibrosis, inflammation, endoplasmic reticulum stress and apoptosis in the livers of rats.

  2018cites this paper
• Elevated transforming growth factor β signaling activation in β‐actin‐knockout mouse embryonic fibroblasts enhances myofibroblast features

  2018cites this paper
• Silymarin and caffeine combination ameliorates experimentally-induced hepatic fibrosis through down-regulation of LPAR1 expression.

  2018cites this paper
• Protective Effect of Phaleria macrocarpa Water Extract (Proliverenol) against Carbon Tetrachloride-Induced Liver Fibrosis in Rats: Role of TNF-α and TGF-β1

  2018cites this paper
• Effect of mangiferin on mRNA expression of transforming growth factor beta in rats with liver fibrosis induced by thioacetamide

  2018influential citation
• Glaucocalyxin A Attenuates the Activation of Hepatic Stellate Cells Through the TGF-β1/Smad Signaling Pathway

  2018cites this paper
• Anti-fibrotic Effects of Synthetic Oligodeoxynucleotide for TGF-β1 and Smad in an Animal Model of Liver Cirrhosis

  2017cites this paper
• Conference Paper MINI REVIEW : LIVER FIBROSIS MECHANISM

  2017cites this paper
• Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway*

  2017cites this paper
• Exosome-Mediated Intercellular Communication between Hepatitis C Virus-Infected Hepatocytes and Hepatic Stellate Cells

  2017cites this paper
• Molecular Effects of Alcohol on Iron Metabolism

  2016cites this paper
• Diet-Induced Obesity Enhances Progression of Hepatocellular Carcinoma through Tenascin-C/Toll-Like Receptor 4 Signaling.

  2016cites this paper
• Dysregulation of redox pathways in liver fibrosis.

  2016cites this paper
• New frontiers in fibrotic disease therapies: The focus of the Joan and Joel Rosenbloom Center for Fibrotic Diseases at Thomas Jefferson University.

  2016cites this paper
• Antifibrotic Therapies: Where Are We Now?

  2016cites this paper
• Adverse outcome pathway development from protein alkylation to liver fibrosis

  2016cites this paper
• A Human Anti-Toll Like Receptor 4 Fab Fragment Inhibits Lipopolysaccharide-Induced Pro-Inflammatory Cytokines Production in Macrophages

  2016cites this paper
• Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver

  2015cites this paper
• Blocking of SMAD4 expression by shRNA effectively inhibits fibrogenesis of human hepatic stellate cells

  2015cites this paper
• Novel insights into the function and dynamics of extracellular matrix in liver fibrosis.

  2015cites this paper
• Potent inhibition of TGF-β signaling pathway regulator Abl: potential therapeutics for hepatic fibrosis

  2015cites this paper
• Bone marrow mononuclear cell transplantation improves mitochondrial bioenergetics in the liver of cholestatic rats.

  2015cites this paper
• Alteration and localization of glycan‐binding proteins in human hepatic stellate cells during liver fibrosis

  2015cites this paper
• Precision-cut liver slices as a model for the early onset of liver fibrosis to test antifibrotic drugs.

  2014cites this paper
• [Role of transforming growth factor-beta in the development of some liver diseases].

  2014influential citation
• The expression and secretion of vimentin in the progression of non-alcoholic steatohepatitis

  2014cites this paper
• UNIVERSIDADE DE SÃO PAULO FACULDADE DE MEDICINA DE RIBEIRÃO PRETO

  2014cites this paper
• ABC transporters as therapeutic targets for liver fibrosis

  2014cites this paper
• Transplantation of bone marrow-derived mesenchymal stem cells after regional hepatic irradiation ameliorates thioacetamide-induced liver fibrosis in rats.

  2014cites this paper
• Developing an in vitro screening assay platform for evaluation of antifibrotic drugs using precision-cut liver slices

  2014cites this paper
• GIV/Girdin is a central hub for pro-fibrogenic signalling networks during liver fibrosis

  2014cites this paper
• Role of NADPH Oxidases in Liver Fibrosis

  2014cites this paper
• Autophagy—a key player in cellular and body metabolism

  2014cites this paper
• Up-Regulation of RACK1 by TGF-β1 Promotes Hepatic Fibrosis in Mice

  2013cites this paper
• Anti-fibrotic effects of puerarin on CCl4-induced hepatic fibrosis in rats possibly through the regulation of PPAR-γ expression and inhibition of PI3K/Akt pathway.

  2013cites this paper
• Liver Injury and the Activation of the Hepatic Myofibroblasts

  2013cites this paper